Because of the roles of dopamine in COVID-19 and CNS diseases, we chose these four drug–UCHL1-binding systems for further MD simulations to clearly elucidate the possible interaction mechanisms between potential targets and drugs. This evidence concerns the gene UCHL1 and COVID-19.